The FDA Takes a Hard Look at Testosterone Therapy
The FDA is reassessing "low-T" treatments, after studies say they hike the risk of heart attack, stroke, and death.
Eight Trips That Take You Further
Plus: The Toughest Agent in the NFL
ON NEWSSTANDS NOW
Sign up to receive the Men’s Journal newsletter and special offers from MJ and its marketing partners.